Search results
Results from the WOW.Com Content Network
Therefore, early and accurate diagnosis of dementia and staging can be essential to proper clinical care. Without the ability to reliably assess dementia across the board, the misuse of anti-dementia compounds could have negative consequences, such as patients receiving the wrong medication, or not receiving treatment in the early stages of ...
Openclipart, also called Open Clip Art Library, is an online media repository of free-content vector clip art.The project hosts over 160,000 free graphics and has billed itself as "the largest community of artists making the best free original clipart for you to use for absolutely any reason".
The MoCA is a one-page 30-point test administered in approximately 10 minutes. [2] The test and administration instructions are available for clinicians online. The test is available in 46 languages and dialects (as of 2017). In this clock drawing task, the subject is asked to draw a clock with the hours and showing the time 2:30.
New research finds a blood test accurately diagnoses Alzheimer’s disease in patients. The blood test was 90% accurate in the study. This blood test is currently available in the U.S.
Of the 698 participants previously seen at a memory clinic, the PrecivityAD2 test was about 90% accurate in identifying the presence of Alzheimer’s disease, while specialists were only 73% valid.
Different forms of art (visual arts, music, etc.) are used for therapy with dementia patients. The forms of art therapy for dementia are numerous and, according to one 2018 study, can include active and/or passive engagement in the arts through "literary (e.g., reading aloud, poetry reciting, or creative writing); performing (e.g., music, dance, theatre) and visual (e.g., gallery visits ...
For premium support please call: 800-290-4726 more ways to reach us
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [ 1 ] and is considered to be the “gold standard” for assessing antidementia treatments.